Afelimomab led to a modest mortality benefit in patients...

Critical Care (BioMed Central) 2005 / 10 Vol. 9; Iss. 5

Afelimomab led to a modest mortality benefit in patients with severe sepsis and elevated interleukin-6 levels

Eliseo Rondon,Ramesh Venkataraman
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Language:
english
Journal:
Critical Care
DOI:
10.1186/cc3798
Date:
October, 2005
File:
PDF, 193 KB
english, 2005
Conversion to is in progress
Conversion to is failed